-
1
-
-
56649103705
-
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
-
Weiner, S. J.; Neragi-Miandoab, S. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J. Cancer Res. Clin. Oncol. 2009, 135, 15-27.
-
(2009)
J. Cancer Res. Clin. Oncol.
, vol.135
, pp. 15-27
-
-
Weiner, S.J.1
Neragi-Miandoab, S.2
-
2
-
-
0036175321
-
The pathogenesis of mesothelioma
-
Carbone, M.; Kratzke, R. A.; Testa, J. R. The pathogenesis of mesothelioma. Semin. Oncol. 2002, 29, 2-17.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 2-17
-
-
Carbone, M.1
Kratzke, R.A.2
Testa, J.R.3
-
3
-
-
3042623428
-
The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma
-
Stewart, D. J.; Martin-Ucar, A.; Pilling, J. E.; Edwards, J. G.; O'byrne, K. J.; Waller, D. A. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann. Thorac. Surg. 2004, 78, 245-252.
-
(2004)
Ann. Thorac. Surg.
, vol.78
, pp. 245-252
-
-
Stewart, D.J.1
Martin-Ucar, A.2
Pilling, J.E.3
Edwards, J.G.4
O'Byrne, K.J.5
Waller, D.A.6
-
4
-
-
3142779111
-
Radiation therapy of mesothelioma: The Heidelberg experience and future aspects
-
Zierhut, D.; Gutwein, S.; Munter, M. W.; Woger, H.; Debus, J. Radiation therapy of mesothelioma: the Heidelberg experience and future aspects. Lung Cancer 2004, 45(Suppl 1), S85-91.
-
(2004)
Lung Cancer
, vol.45
, Issue.SUPPL. 1
-
-
Zierhut, D.1
Gutwein, S.2
Munter, M.W.3
Woger, H.4
Debus, J.5
-
5
-
-
16244362744
-
Chemotherapy options and new advances in malignant pleural mesothelioma
-
Steele, J. P.; Klabatsa, A. Chemotherapy options and new advances in malignant pleural mesothelioma. Ann. Oncol. 2005, 16, 345-351.
-
(2005)
Ann. Oncol.
, vol.16
, pp. 345-351
-
-
Steele, J.P.1
Klabatsa, A.2
-
6
-
-
0036837690
-
Activity of chemotherapy and immunotherapy on malignant mesothelioma: A systematic review of the literature with meta-analysis
-
Berghmans, T.; Paesmans, M.; Lalami, Y.; Louviaux, I.; Luce, S.; Mascaux, C.; Meert, A. P.; Sculier, J. P. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer 2002, 38, 111-121.
-
(2002)
Lung Cancer
, vol.38
, pp. 111-121
-
-
Berghmans, T.1
Paesmans, M.2
Lalami, Y.3
Louviaux, I.4
Luce, S.5
Mascaux, C.6
Meert, A.P.7
Sculier, J.P.8
-
7
-
-
0041629528
-
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
-
Vogelzang, N. J.; Rusthoven, J. J.; Symanowski, J.; Denham, C.; Kaukel, E.; Ruffie, P.; Gatzemeier, U.; Boyer, M.; Emri, S.; Manegold, C.; Niyikiza, C.; Paoletti, P. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J. Clin. Oncol. 2003, 21, 2636-2644.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 2636-2644
-
-
Vogelzang, N.J.1
Rusthoven, J.J.2
Symanowski, J.3
Denham, C.4
Kaukel, E.5
Ruffie, P.6
Gatzemeier, U.7
Boyer, M.8
Emri, S.9
Manegold, C.10
Niyikiza, C.11
Paoletti, P.12
-
8
-
-
34547765871
-
Preliminary data suggestive of a novel translational approach to mesothelioma treatment: Imatinib mesylate with gemcitabine or pemetrexed
-
Bertino, P.; Porta, C.; Barbone, D.; Germano, S.; Busacca, S.; Pinato, S.; Tassi, G.; Favoni, R.; Gaudino, G.; Mutti, L. Preliminary data suggestive of a novel translational approach to mesothelioma treatment: imatinib mesylate with gemcitabine or pemetrexed. Thorax 2007, 62, 690-695.
-
(2007)
Thorax
, vol.62
, pp. 690-695
-
-
Bertino, P.1
Porta, C.2
Barbone, D.3
Germano, S.4
Busacca, S.5
Pinato, S.6
Tassi, G.7
Favoni, R.8
Gaudino, G.9
Mutti, L.10
-
9
-
-
38949184992
-
Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts
-
Bertino, P.; Piccardi, F.; Porta, C.; Favoni, R.; Cilli, M.; Mutti, L.; Gaudino, G. Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts. Clin. Cancer Res. 2008, 14, 541-548.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 541-548
-
-
Bertino, P.1
Piccardi, F.2
Porta, C.3
Favoni, R.4
Cilli, M.5
Mutti, L.6
Gaudino, G.7
-
10
-
-
0025330611
-
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody
-
Dazzi, H.; Hasleton, P. S.; Thatcher, N.; Wilkes, S.; Swindell, R.; Chatterjee, A. K. Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody. Br. J. Cancer 1990, 61, 924-926.
-
(1990)
Br. J. Cancer
, vol.61
, pp. 924-926
-
-
Dazzi, H.1
Hasleton, P.S.2
Thatcher, N.3
Wilkes, S.4
Swindell, R.5
Chatterjee, A.K.6
-
11
-
-
0023484719
-
Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines
-
Gerwin, B. I.; Lechner, J. F.; Reddel, R. R.; Roberts, A. B.; Robbins, K. C.; Gabrielson, E. W.; Harris, C. C. Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 1987, 47, 6180-6184.
-
(1987)
Cancer Res.
, vol.47
, pp. 6180-6184
-
-
Gerwin, B.I.1
Lechner, J.F.2
Reddel, R.R.3
Roberts, A.B.4
Robbins, K.C.5
Gabrielson, E.W.6
Harris, C.C.7
-
12
-
-
0027195940
-
Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules
-
Lee, T. C.; Zhang, Y.; Aston, C.; Hintz, R.; Jagirdar, J.; Perle, M. A.; Burt, M.; Rom, W. N. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res. 1993, 53, 2858-2864.
-
(1993)
Cancer Res.
, vol.53
, pp. 2858-2864
-
-
Lee, T.C.1
Zhang, Y.2
Aston, C.3
Hintz, R.4
Jagirdar, J.5
Perle, M.A.6
Burt, M.7
Rom, W.N.8
-
13
-
-
0026576726
-
Insulin-like growth factors and cancer
-
Macaulay, V. M. Insulin-like growth factors and cancer. Br. J. Cancer 1992, 65, 311-320.
-
(1992)
Br. J. Cancer
, vol.65
, pp. 311-320
-
-
Macaulay, V.M.1
-
14
-
-
0035068834
-
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
-
Strizzi, L.; Catalano, A.; Vianale, G.; Orecchia, S.; Casalini, A.; Tassi, G.; Puntoni, R.; Mutti, L.; Procopio, A. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J. Pathol. 2001, 193, 468-475.
-
(2001)
J. Pathol.
, vol.193
, pp. 468-475
-
-
Strizzi, L.1
Catalano, A.2
Vianale, G.3
Orecchia, S.4
Casalini, A.5
Tassi, G.6
Puntoni, R.7
Mutti, L.8
Procopio, A.9
-
15
-
-
0026046037
-
Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors
-
Versnel, M. A.; Claesson-Welsh, L.; Hammacher, A.; Bouts, M. J.; Van Der Kwast, T. H.; Eriksson, A.; Willemsen, R.; Weima, S. M.; Hoogsteden, H. C.; Hagemeijer, A.; Heldin, C. -H. Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. Oncogene 1991, 6, 2005-2011.
-
(1991)
Oncogene
, vol.6
, pp. 2005-2011
-
-
Versnel, M.A.1
Claesson-Welsh, L.2
Hammacher, A.3
Bouts, M.J.4
Van Der Kwast, T.H.5
Eriksson, A.6
Willemsen, R.7
Weima, S.M.8
Hoogsteden, H.C.9
Hagemeijer, A.10
Heldin, C.-H.11
-
17
-
-
0035884231
-
The epidermal growth factor receptor: From mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia
-
Arteaga, C. L. The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J. Clin. Oncol. 2001, 19, 32S-40S.
-
(2001)
J. Clin. Oncol.
, vol.19
-
-
Arteaga, C.L.1
-
18
-
-
0031887743
-
Protein kinase inhibitors: The tyrosine-specific protein kinases
-
Lawrence, D. S.; Niu, J. Protein kinase inhibitors: the tyrosine-specific protein kinases. Pharmacol. Ther. 1998, 77, 81-114.
-
(1998)
Pharmacol. Ther.
, vol.77
, pp. 81-114
-
-
Lawrence, D.S.1
Niu, J.2
-
19
-
-
0035892346
-
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression
-
Anderson, N. G.; Ahmad, T.; Chan, K.; Dobson, R.; Bundred, N. J. ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int. J. Cancer 2001, 94, 774-782.
-
(2001)
Int. J. Cancer
, vol.94
, pp. 774-782
-
-
Anderson, N.G.1
Ahmad, T.2
Chan, K.3
Dobson, R.4
Bundred, N.J.5
-
20
-
-
0034068319
-
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor
-
Ciardiello, F.; Caputo, R.; Bianco, R.; Damiano, V.; Pomatico, G.; De Placido, S.; Bianco, A. R.; Tortora, G. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin. Cancer Res. 2000, 6, 2053-2063.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 2053-2063
-
-
Ciardiello, F.1
Caputo, R.2
Bianco, R.3
Damiano, V.4
Pomatico, G.5
De Placido, S.6
Bianco, A.R.7
Tortora, G.8
-
21
-
-
0030783173
-
Inhibitors of tyrosine kinase
-
Klohs, W. D.; Fry, D. W.; Kraker, A. J. Inhibitors of tyrosine kinase. Curr. Opin. Oncol. 1997, 9, 562-568.
-
(1997)
Curr. Opin. Oncol.
, vol.9
, pp. 562-568
-
-
Klohs, W.D.1
Fry, D.W.2
Kraker, A.J.3
-
22
-
-
0037109014
-
ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy
-
Wakeling, A. E.; Guy, S. P.; Woodburn, J. R.; Ashton, S. E.; Curry, B. J.; Barker, A. J.; Gibson, K. H. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res. 2002, 62, 5749-5754.
-
(2002)
Cancer Res.
, vol.62
, pp. 5749-5754
-
-
Wakeling, A.E.1
Guy, S.P.2
Woodburn, J.R.3
Ashton, S.E.4
Curry, B.J.5
Barker, A.J.6
Gibson, K.H.7
-
23
-
-
0034489914
-
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase
-
Sirotnak, F. M.; Zakowski, M. F.; Miller, V. A.; Scher, H. I.; Kris, M. G. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Clin. Cancer Res. 2000, 6, 4885-4892.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 4885-4892
-
-
Sirotnak, F.M.1
Zakowski, M.F.2
Miller, V.A.3
Scher, H.I.4
Kris, M.G.5
-
24
-
-
0037105665
-
Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma
-
Janne, P. A.; Taffaro, M. L.; Salgia, R.; Johnson, B. E. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res. 2002, 62, 5242-5247.
-
(2002)
Cancer Res.
, vol.62
, pp. 5242-5247
-
-
Janne, P.A.1
Taffaro, M.L.2
Salgia, R.3
Johnson, B.E.4
-
25
-
-
0036178251
-
New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agents
-
Nowak, A. K.; Lake, R. A.; Kindler, H. L.; Robinson, B. W. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin. Oncol. 2002, 29, 82-96.
-
(2002)
Semin. Oncol.
, vol.29
, pp. 82-96
-
-
Nowak, A.K.1
Lake, R.A.2
Kindler, H.L.3
Robinson, B.W.4
-
26
-
-
0032904576
-
Establishment of four new mesothelioma cell lines: Characterization by ultrastructural and immunophenotypic analysis
-
Orengo, A. -M.; Spoletini, L.; Procopio, A.; Favoni, R. E.; De Cupis, A.; Ardizzoni, A.; Castagneto, B.; Ribotta, M.; Betta, P. G.; Ferrini, S.; Mutti, L. Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis. Eur. Respir. J. 1999, 13, 527-534.
-
(1999)
Eur. Respir. J.
, vol.13
, pp. 527-534
-
-
Orengo, A.-M.1
Spoletini, L.2
Procopio, A.3
Favoni, R.E.4
De Cupis, A.5
Ardizzoni, A.6
Castagneto, B.7
Ribotta, M.8
Betta, P.G.9
Ferrini, S.10
Mutti, L.11
-
27
-
-
0026608576
-
Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin-6 production as a common feature
-
Schmitter, D.; Lauber, B.; Fagg, B.; Stahel, R. A. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int. J. Cancer 1992, 51, 296-301.
-
(1992)
Int. J. Cancer
, vol.51
, pp. 296-301
-
-
Schmitter, D.1
Lauber, B.2
Fagg, B.3
Stahel, R.A.4
-
28
-
-
0043209011
-
Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines
-
De Cupis, A.; Semino, C.; Pirani, P.; Loprevite, M.; Ardizzoni, A.; Favoni, R. E. Enhanced effectiveness of last generation antiblastic compounds vs. cisplatin on malignant pleural mesothelioma cell lines. Eur. J. Pharmacol. 2003, 473, 83-95.
-
(2003)
Eur. J. Pharmacol.
, vol.473
, pp. 83-95
-
-
De Cupis, A.1
Semino, C.2
Pirani, P.3
Loprevite, M.4
Ardizzoni, A.5
Favoni, R.E.6
-
29
-
-
37349047939
-
17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: Reversal by gefitinib pretreatment
-
Pattarozzi, A.; Gatti, M.; Barbieri, F.; Wurth, R.; Porcile, C.; Lunardi, G.; Ratto, A.; Favoni, R.; Bajetto, A.; Ferrari, A.; Florio, T. 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol. Pharmacol. 2008, 73, 191-202.
-
(2008)
Mol. Pharmacol.
, vol.73
, pp. 191-202
-
-
Pattarozzi, A.1
Gatti, M.2
Barbieri, F.3
Wurth, R.4
Porcile, C.5
Lunardi, G.6
Ratto, A.7
Favoni, R.8
Bajetto, A.9
Ferrari, A.10
Florio, T.11
-
30
-
-
65449188718
-
Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
-
Griffero, F.; Daga, A.; Marubbi, D.; Capra, M. -C.; Melotti, A.; Pattarozzi, A.; Gatti, M.; Bajetto, A.; Porcile, C.; Barbieri, F.; Favoni, R. E.; Lo Casto, M.; Zona, G.; Spaziante, R.; Florio, T.; Corte, G. Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors. J. Biol. Chem. 2009, 284, 7138-7148.
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 7138-7148
-
-
Griffero, F.1
Daga, A.2
Marubbi, D.3
Capra, M.C.4
Melotti, A.5
Pattarozzi, A.6
Gatti, M.7
Bajetto, A.8
Porcile, C.9
Barbieri, F.10
Favoni, R.E.11
Lo Casto, M.12
Zona, G.13
Spaziante, R.14
Florio, T.15
Corte, G.16
-
31
-
-
24944553762
-
Stromal cellderived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
-
Porcile, C.; Bajetto, A.; Barbieri, F.; Barbero, S.; Bonavia, R.; Biglieri, M.; Pirani, P.; Florio, T.; Schettini, G. Stromal cellderived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp. Cell Res. 2005, 308, 241-253.
-
(2005)
Exp. Cell Res.
, vol.308
, pp. 241-253
-
-
Porcile, C.1
Bajetto, A.2
Barbieri, F.3
Barbero, S.4
Bonavia, R.5
Biglieri, M.6
Pirani, P.7
Florio, T.8
Schettini, G.9
-
32
-
-
0026496890
-
Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity
-
Florio, T.; Pan, M. G.; Newman, B.; Hershberger, R. E.; Civelli, O.; Stork, P. J. Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J. Biol. Chem. 1992, 267, 24169-24172.
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 24169-24172
-
-
Florio, T.1
Pan, M.G.2
Newman, B.3
Hershberger, R.E.4
Civelli, O.5
Stork, P.J.6
-
33
-
-
52649139943
-
Over-expression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas
-
Barbieri, F.; Bajetto, A.; Stumm, R.; Pattarozzi, A.; Porcile, C.; Zona, G.; Dorcaratto, A.; Ravetti, J. L.; Minuto, F.; Spaziante, R.; Schettini, G.; Ferone, D.; Florio, T. Over-expression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin. Cancer Res. 2008, 14, 5022-5032.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 5022-5032
-
-
Barbieri, F.1
Bajetto, A.2
Stumm, R.3
Pattarozzi, A.4
Porcile, C.5
Zona, G.6
Dorcaratto, A.7
Ravetti, J.L.8
Minuto, F.9
Spaziante, R.10
Schettini, G.11
Ferone, D.12
Florio, T.13
-
34
-
-
66549105990
-
The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization
-
Iuliano, R.; Raso, C.; Quintiero, A.; Pera, I. L.; Pichiorri, F.; Palumbo, T.; Palmieri, D.; Pattarozzi, A.; Florio, T.; Viglietto, G.; Trapasso, F.; Croce, C. M.; Fusco, A. The eighth fibronectin type III domain of protein tyrosine phosphatase receptor J influences the formation of protein complexes and cell localization. J. Biochem. 2009, 145, 377-385.
-
(2009)
J. Biochem.
, vol.145
, pp. 377-385
-
-
Iuliano, R.1
Raso, C.2
Quintiero, A.3
Pera, I.L.4
Pichiorri, F.5
Palumbo, T.6
Palmieri, D.7
Pattarozzi, A.8
Florio, T.9
Viglietto, G.10
Trapasso, F.11
Croce, C.M.12
Fusco, A.13
-
35
-
-
0034705479
-
Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK
-
Colucci-D'Amato, G. L.; D'Alessio, A.; Califano, D.; Calì, G.; Rizzo, C.; Nitsch, L.; Santelli, G.; de Franciscis, V. Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK. J. Biol. Chem. 2000, 275, 19306-19314.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 19306-19314
-
-
Colucci-D'Amato, G.L.1
D'Alessio, A.2
Califano, D.3
Calì, G.4
Rizzo, C.5
Nitsch, L.6
Santelli, G.7
De Franciscis, V.8
-
36
-
-
0242551370
-
Chronic activation of ERK and neurodegenerative diseases
-
Colucci-D'Amato, G. L.; Perrone-Campano, C.; di Porzio, U. Chronic activation of ERK and neurodegenerative diseases. BioEssay 2003, 25, 1085-1095.
-
(2003)
BioEssay
, vol.25
, pp. 1085-1095
-
-
Colucci-D'Amato, G.L.1
Perrone-Campano, C.2
Di Porzio, U.3
-
37
-
-
0037388251
-
ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells
-
Anido, J.; Matar, P.; Albanell, J.; Guzman, M.; Rojo, F.; Arribas, J.; Averbuch, S.; Baselga, J. ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. Clin. Cancer Res. 2003, 9, 1274-1283.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 1274-1283
-
-
Anido, J.1
Matar, P.2
Albanell, J.3
Guzman, M.4
Rojo, F.5
Arribas, J.6
Averbuch, S.7
Baselga, J.8
-
38
-
-
0033986112
-
Anticancer drug targets: Growth factors and growth factor signaling
-
Gibbs, J. B. Anticancer drug targets: growth factors and growth factor signaling. J. Clin. Invest. 2000, 105, 9-13.
-
(2000)
J. Clin. Invest.
, vol.105
, pp. 9-13
-
-
Gibbs, J.B.1
-
39
-
-
65849296369
-
Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines
-
Nutt, J. E.; O'Toole K.; Gonzalez D.; Lunec, J. Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines. Eur. J. Cancer 2009, 45(9), 1684-1691.
-
(2009)
Eur. J. Cancer
, vol.45
, Issue.9
, pp. 1684-1691
-
-
Nutt, J.E.1
O'Toole, K.2
Gonzalez, D.3
Lunec, J.4
-
40
-
-
0031974705
-
Therapeutic application of anti-growth factor receptor antibodies
-
Fan, Z.; Mendelsohn, J. Therapeutic application of anti-growth factor receptor antibodies. Curr. Opin. Oncol. 1998, 10, 67-73.
-
(1998)
Curr. Opin. Oncol.
, vol.10
, pp. 67-73
-
-
Fan, Z.1
Mendelsohn, J.2
-
41
-
-
0028106163
-
Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor
-
Ward, W. H.; Cook, P. N.; Slater, A. M.; Davies, D. H.; Holdgate, G. A.; Green, L. R. Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem. Pharmacol. 1994, 48, 659-666.
-
(1994)
Biochem. Pharmacol.
, vol.48
, pp. 659-666
-
-
Ward, W.H.1
Cook, P.N.2
Slater, A.M.3
Davies, D.H.4
Holdgate, G.A.5
Green, L.R.6
-
42
-
-
0036473508
-
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")
-
Sewell, J. M.; Macleod, K. G.; Ritchie, A.; Smyth, J. F.; Langdon, S. P. Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa"). Br. J. Cancer 2002, 86, 456-462.
-
(2002)
Br. J. Cancer
, vol.86
, pp. 456-462
-
-
Sewell, J.M.1
Macleod, K.G.2
Ritchie, A.3
Smyth, J.F.4
Langdon, S.P.5
-
43
-
-
0030801361
-
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
-
Arteaga, C. L.; Ramsey, T. T.; Shawver, L. K.; Guyer, C. A. Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. J. Biol. Chem. 1997, 272, 23247-23254.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 23247-23254
-
-
Arteaga, C.L.1
Ramsey, T.T.2
Shawver, L.K.3
Guyer, C.A.4
-
44
-
-
0035423120
-
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors
-
Lichtner, R. B.; Menrad, A.; Sommer, A.; Klar, U.; Schneider, M. R. Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. Cancer Res. 2001, 61, 5790-5795.
-
(2001)
Cancer Res.
, vol.61
, pp. 5790-5795
-
-
Lichtner, R.B.1
Menrad, A.2
Sommer, A.3
Klar, U.4
Schneider, M.R.5
-
45
-
-
57349172709
-
Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib
-
Servidei, T.; Riccardi, A.; Mozzetti, S.; Ferlini, C.; Riccardi, R. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib. Int. J. Cancer 2008, 123, 2939-2949.
-
(2008)
Int. J. Cancer
, vol.123
, pp. 2939-2949
-
-
Servidei, T.1
Riccardi, A.2
Mozzetti, S.3
Ferlini, C.4
Riccardi, R.5
|